Precision cardiology Market is Anticipated to Register Impressive Growth Through 2027

Increasing prevalence of cardiovascular diseases along with the launch of optimized treatment solutions to meet the diverse treatment needs of CVD patient’s is driving the growth of global precision cardiology market.

According to TechSci report on, “Precision cardiology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2023-2027”, the global precision cardiology market is expected to grow at an impressive CAGR during the forecast period of 2023-2027, owing to the rising number of several cardiovascular diseases (CVD) such as heart attacks, coronary artery disease, heart stroke, congenital heart disease, etc. In addition, the rising adoption of sedentary lifestyle, lack of physical activities, high consumption of alcohol, increased intake of food high in sodium, sugar and fats are also adding to the increasing rates of CVDs across the globe. According to a report by the World Health Organization, cardiovascular diseases are the leading cause of deaths across the globe. In 2019, approx. 17.9 million people died from CVDs, which accounts for 32% of the overall global deaths. Out of these, nearly 85% of CVD-related deaths were either due to heart attack or stroke. As a result, the demand for tailored treatment solutions to treat and prevent CVD is surging, which is creating a positive impact on the global precision cardiology market. Besides, growing awareness regarding the benefits associated with precision cardiology has resulted in its increased adoption by the healthcare providers. Furthermore, biotechnology companies are investing in the development of precision cardiology tests based on sequencing technologies. This is expected to support the physicians in offering precision care in the field of cardiology. Market players are also actively engaging in new product launches to address the diverse treatment needs of cardiovascular diseases, which is expected to further boost the market growth in the coming years.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "GLOBAL PRECISION CARDIOLOGY MARKET"

The global precision cardiology market is segmented on the basis of offering, sample type, technology, application, end users, competitive landscape, and regional distribution. Based on offering, the market is bifurcated into products and services. The product segment is projected to hold a prominent market share in the global precision cardiology market in the coming years as they are used widely utilized in performing many cardiology tests or treatments and surgeries.

Based on sample type, the market is divided into between blood and non-blood. Among these, the blood segment is anticipated to hold a significant market share over the forecast period. This is primarily because blood test includes a series of assessments and helps the healthcare professional in diagnosing different types of blood levels, exclude the risk of heart attacks, and check if the patient has any infection or anaemia. The most common type of blood tests used to assess the cardiovascular and heart condition include cardiac enzyme tests and full body count (FBC). As a result, the blood sample segment is estimated to have a higher significance than the non-blood sample segment in the global precision cardiology market during the forecast period.

By technology, the market is bifurcated into sequencing, polymerase chain reaction, microarray, and others. Among these, the sequencing segment is projected to hold a considerable market share in the coming years. Compared to other alternatives, the sequencing technology has the ability to detect a higher percentage of differentially expressed genes, particularly genes with low expression. Moreover, unlike microarray, sequencing does not require species. It can detect novel transcripts, gene fusions, and other previously unknown changes that microarrays cannot. As a result, sequencing technology is highly preferred by cardiologists.

On the basis of end user, the global market is segmented hospitals & clinics, academic & research institutions, and others. Among these, the academic & research institutions are anticipated to hold a prominent market share in the coming years. This is mainly because precision cardiology is still under research and development phase. Several institutes and physicians are increasingly incorporating various technologies to bring out the best-in-class tailored approach to deal with the distinctive and critical treatment needs of cardiovascular diseases. As a result, precision cardiology is conducted more in academic and research institutes than hospitals & clinics.

A list of major market players of the global precision cardiology market includes:

• Eurofins Genomics LLC
• Laboratory Corporation of America Holdings
• Thermos Fischer Scientific, Inc.
• PerkinElmer, Inc.
• Sema4 OpCo, Inc.
• Quest Diagnostics Inc.
• OraSure Technologies, Inc.
• OPKO Health, Inc.
• Invitae Corporation
• Illumina, Inc.
• Fulgent Genetics, Inc.
• Exact Sciences Corporation
• CENTOGENE N.V.
• Konica Minolta, Inc.
• Devyser Diagnostics AB

DOWNLOAD FREE SAMPLE REPORT

Customers can also request for 10% free customization on this report.

“North America is projected to hold a significant share of the global precision cardiology market during the forecast period. This is primarily due to the presence of leading market players such as PerkinElmer Inc, Quest Diagnostics, and Laboratory Corporation of America Holdings, coupled with the increasing adoption of high-fidelity precision cardiology tests to diagnose CVDs. Moreover, the rising investments by the federal organizations for the development of precision cardiology tests are also supporting the market growth in the region. Besides, the Asia-Pacific is anticipated to be the fastest growing region during the forecast period. This is majorly accredited to the rising incidences of cardiovascular diseases, rising healthcare awareness, and emerging economy resulting in higher focus on research and development of advanced cardiology tests,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Precision Cardiology Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Offering (Products v/s Service), By Sample Type (Blood v/s Non-Blood), By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Others), By Application (Cardiomyopathy, Arrhythmia, Aortopathy and Vascular Diseases, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others) and Region” has evaluated the future growth potential of global precision cardiology market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global precision cardiology market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com